MedTrace Logo

Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes

NCT04671043 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2023-03-14

No results posted yet for this study

Summary

This project will aim to investigate the clinical efficacy and metabolic effects of a pre-exercise dose of caffeine with a low (10g) dose of carbohydrate (CAF+lowCHO) without modification of insulin degludec on exercise metabolism in people with T1D.

Conditions

  • Caffeine and Carbohydrate
  • Carbohydrate Only
  • Placebo

Interventions

DIETARY_SUPPLEMENT

Caffeine and glucose

Caffeine and glucose powder dissolved in water

DIETARY_SUPPLEMENT

Glucose alone

Glucose powder dissolved in water

DIETARY_SUPPLEMENT

Placebo

Artificial sweetener dissolved in water

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Christoph Stettler, MD · University of Bern

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-04
Primary Completion
2023-02-02
Completion
2023-02-02

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04671043 on ClinicalTrials.gov